Effect of combination therapy with repaglinide and metformin hydrochloride on glycemic control in Japanese patients with type 2 diabetes mellitus

AIMS/INTRODUCTION: We investigated the efficacy and safety of repaglinide as an add‐on therapy for Japanese patients with type 2 diabetes mellitus receiving metformin monotherapy (at a dose of 1,500 mg/day, mainly) in addition to diet and exercise. MATERIALS AND METHODS: In the 16‐week multicenter,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamori, Ryuzo, Kaku, Kohei, Hanafusa, Toshiaki, Oikawa, Tatsuya, Kageyama, Shigeru, Hotta, Nigishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025226/
https://www.ncbi.nlm.nih.gov/pubmed/24843740
http://dx.doi.org/10.1111/jdi.12121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025226/
https://www.ncbi.nlm.nih.gov/pubmed/24843740
http://dx.doi.org/10.1111/jdi.12121

Ejemplares similares